Not exact matches
Currently marketed for research use by Biofluidica, the
test's microfluidic channels use specific
cancer antibodies to detect capture circulating tumor cells.
If they are, ctDNA
testing could become a way of detecting breast
cancer metastasis much earlier than is
currently possible.
Researchers are
currently testing pembrolizumab to determine if it has the same result in other
cancers, as well as trying to combine pembrolizumab with other therapies.
Currently, doctors use a variety of imaging techniques and
tests to diagnose and monitor prostate
cancer including PSA blood
tests, magnetic resonance imaging (MRI), single photon emission computed tomography (SPECT), positron emission tomography (PET), and computerized tomography (CT) scans.
The authors suggest that HAND2 methylation «could be applied to triage women who present with postmenopausal bleeding (
currently ~ 90 % of women who present with this symptom and are
cancer - free must undergo endometrial biopsy for a definitive diagnosis) and could be further employed as a
test to early detect or even predict the risk for endometrial
cancer and response to preventative treatment.»
Drug derivatives of JQ1 are
currently being
tested in clinical trials for people with
cancer.
A blood
test that could detect precancerous polyps would be an improvement over other non-invasive colon
cancer screening mechanisms
currently available.
The most widely used screening
test for prostate
cancer is
currently the PSA
test, which measures the blood's level of PSA — a protein that is naturally produced by the prostate gland and is typically increased when
cancer is present.
A new therapeutic approach
tested by a team from Maisonneuve - Rosemont Hospital (CIUSSS - EST, Montreal) and the University of Montreal gives promising results for the treatment of multiple myeloma, a
cancer of the bone marrow
currently considered incurable with conventional chemotherapy and for which the average life expectancy is about 6 or 7 years.
Many countries are
currently considering switching from classic Pap
tests to primary HPV
tests for cervical
cancer screening, based on the strong evidence linking cervical abnormalities and infection with certain HPV types, and data suggesting that HPV
tests detect more high - grade precancerous lesions.
«The good news is that this finding predicts that patients missing either gene should be sensitive to new therapies targeting focal adhesion enzymes, which are
currently being
tested in early - stage clinical trials,» says Shaw, who is also a member of the Moores
Cancer Center and an adjunct professor at the University of California, San Diego.
This study, conducted by the Gynecologic Oncology Group, a cooperative group funded by the National
Cancer Institute, was the second to
test bevacizumab under these conditions (first chemotherapy for platinum - sensitive recurrence), a use for which bevacizumab is not
currently approved by the Food and Drug Administration.
The technique is
currently being
tested in a number of clinical applications, including imaging breast tumors, detecting skin
cancer, and tracking blood oxygenation in tissues.
«Our next step is to see how long we can extend the cycling pattern, and
test some of the STAT3 inhibitors
currently in clinical trials for other indications such as
cancer, as this could accelerate
testing in humans,» added Sacco.
«We have shown how a simple blood
test has the potential to accurately predict which patients will relapse from breast
cancer, much earlier than we can
currently.
A new blood
test seems to be more than twice as good at detecting bowel
cancer than the method
currently used to screen for polyps and early bowel
cancer
The study sets the stage for the development of more - sensitive and specific non-invasive
tests for prostate
cancer than those
currently available, which could result in fewer unnecessary prostate biopsies with less treatment - related morbidity, according to a new study in The Journal of Molecular Diagnostics.
This new drug — AZD3965 — is
currently in clinical trials, but it has not yet been
tested in small cell lung
cancer.»
A simple blood
test is
currently in development that could help predict the likelihood of a woman developing breast
cancer, even in the absence of a high - risk BRCA1 gene mutation, according to research published in the open access journal Genome Medicine.
Currently,
testing for Lynch syndrome genes is generally only done when someone has a personal or family history of colon or uterine
cancer.
«We
tested a drug
currently used for
cancer treatment (vorinostat (Zolinza)-RRB- and found that it reduced average daily seizures in zebrafish and mouse models by 60 per cent,» says Kurrasch.
It is
currently being
tested not only for correcting genetic defects, but also for treating
cancer and other acquired diseases.
Strategies to manipulate the PD - 1 pathway are
currently being
tested in clinical trials for
cancer and HIV / AIDS.
And the types of potentially treatable
cancers are growing:
Currently, more than 100 active or recruiting US clinical trials are
testing checkpoint inhibitors to treat bladder
cancer, liver
cancer, and pancreatic
cancer, among others.
Relative to the PTEN
testing criteria
currently endorsed by the National Comprehensive
Cancer Network (NCCN), the CC score is less complex to use, more accurate and can provide individualized estimates of one's probability of harboring a PTEN gene mutation.
The King lab is
currently testing these novel
cancer therapies in mouse models of metastatic breast and prostate
cancer through the use of whole body luminescence imaging.
The Pap
test is widely used to screen for cervical
cancer, but
currently there is no routine screening method for ovarian and endometrial
cancers.
March 29, 2018 - Scientists at Stanford University are
currently preparing the first human
test of a
cancer «vaccine,» a treatment that eliminated up to 97 percent of tumors during trials with mice.
TTFields is
currently being
tested for other
cancers in various clinical trials, presented in this website.
If you have had or
currently have breast
cancer and want to know your HER - 2 / neu status, your physician can request the
test to be performed on archival tumor material.
Though other canine
cancer detection
tests are
currently being used by veterinarians, VDI TKcanine + is different because it confirms
cancer earlier without having to use expensive radiology.
Frequent blood
tests are
currently used to evaluate
cancer patients» tolerance to a particular treatment dosage.
At one time or another, 20 % of women nationwide have used Planned Parenthood's services;
currently, the organization operates more than 800 clinics across the country, performs a million Pap
tests and more than 800,000 breast exams each year (both critical to the early detection of
cancer), and provides nearly 4 million
tests and treatments for sexually transmitted infections.
BOSTON - Yesterday, the House Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies issued a 2016 fiscal year funding proposal that would eliminate the Title X Family Planning program, cutting health care - including family planning services, well - woman exams, lifesaving
cancer screenings, birth control, and
testing and treatments for sexually transmitted infections - that nearly 4.6 million people, including approximately 1.5 million Planned Parenthood patients,
currently rely on.
Although there are
currently no good
tests for ovarian
cancer, it can sometimes be caught early.